LORIA, Paola
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14819
EU - Europa 6341
AS - Asia 999
SA - Sud America 21
AF - Africa 13
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 8
Totale 22210
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14799
GB - Regno Unito 2498
SE - Svezia 934
IT - Italia 864
DE - Germania 720
UA - Ucraina 538
TR - Turchia 452
CN - Cina 396
FI - Finlandia 220
BG - Bulgaria 204
FR - Francia 173
BE - Belgio 48
RU - Federazione Russa 43
IN - India 42
NL - Olanda 28
MY - Malesia 21
CA - Canada 15
JP - Giappone 15
ES - Italia 14
IE - Irlanda 14
IR - Iran 12
BD - Bangladesh 11
CL - Cile 8
TW - Taiwan 8
AU - Australia 7
CH - Svizzera 7
EU - Europa 7
KR - Corea 7
RO - Romania 7
SG - Singapore 7
SI - Slovenia 6
AT - Austria 5
ET - Etiopia 5
MX - Messico 5
AR - Argentina 4
BR - Brasile 4
HK - Hong Kong 4
PH - Filippine 4
UG - Uganda 4
CY - Cipro 3
GE - Georgia 3
GR - Grecia 3
VN - Vietnam 3
CZ - Repubblica Ceca 2
EC - Ecuador 2
EG - Egitto 2
HR - Croazia 2
HU - Ungheria 2
KW - Kuwait 2
NZ - Nuova Zelanda 2
PK - Pakistan 2
PL - Polonia 2
TH - Thailandia 2
TJ - Tagikistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BF - Burkina Faso 1
BO - Bolivia 1
BY - Bielorussia 1
ID - Indonesia 1
JO - Giordania 1
KZ - Kazakistan 1
LV - Lettonia 1
MD - Moldavia 1
MU - Mauritius 1
NO - Norvegia 1
PE - Perù 1
PT - Portogallo 1
RS - Serbia 1
VE - Venezuela 1
Totale 22210
Salva come PNG Salva come JPEG
Città #
Fairfield 2189
Southend 2017
Woodbridge 1601
Houston 1276
Jacksonville 1218
Chandler 1197
Ashburn 885
Dearborn 796
Ann Arbor 776
Seattle 770
Wilmington 761
Cambridge 720
Nyköping 546
Modena 299
Izmir 283
San Diego 235
Princeton 220
Sofia 204
Eugene 201
Beijing 181
Des Moines 166
Grafing 101
Falls Church 86
London 64
Bremen 58
Brussels 45
Redwood City 39
Norwalk 35
Kunming 34
San Mateo 33
Boardman 32
Rome 32
Fremont 31
Hefei 31
Milan 30
Helsinki 24
Nanjing 19
Verona 19
Jinan 17
Dublin 14
Guangzhou 14
Nanchang 14
Bari 12
New York 12
Bologna 11
Indiana 10
Auburn Hills 9
Augusta 9
Florence 9
Islington 9
Shenyang 9
Formia 8
Genova 8
Leawood 8
Mountain View 8
Saint Petersburg 8
San Francisco 8
Toronto 8
Amsterdam 7
Baotou 7
Fuzhou 7
Taipei 7
Chengdu 6
Chongqing 6
Dhaka 6
Istanbul 6
Madrid 6
Monmouth Junction 6
Monza 6
Napoli 6
Parma 6
Phoenix 6
Rio Saliceto 6
Santeramo in Colle 6
Sydney 6
Bangalore 5
Chicago 5
Hebei 5
Livorno 5
Los Angeles 5
Nishinotoindori 5
Philadelphia 5
Shanghai 5
Avigliano 4
Busto Arsizio 4
Castelnuovo Rangone 4
Clearwater 4
Kampala 4
Molise 4
Mumbai 4
Ningbo 4
Paris 4
Piemonte 4
Romainville 4
San Giovanni la Punta 4
Shaoxing 4
Torino 4
Arienzo 3
Buffalo 3
Cagliari 3
Totale 17670
Salva come PNG Salva come JPEG
Nome #
Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study 279
Herpesvirus DNA is frequently detected in liver tissue from hepatitis C patients 250
Suppression of bile acid synthesis, but not of hepatic cholesterol 7alpha-hydroxylase expression, by obstructive cholestasis in humans 204
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 199
ABCB4 and ABCB11 mutations in intrahepatic cholestasis of pregnancy in an Italian population 196
Effects of bile duct ligation and cholic acid treatment on fatty liver in two rat models of non-alcoholic fatty liver disease 190
Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes 188
Age-associated alterations in cholesterol homeostasis: evidence from a cross-sectional study in a Northern Italy population. 186
Nonalcoholic Fatty Liver Disease in HIV-Infected Patients Referred to a Metabolic Clinic: Prevalence, Characteristics, and Predictors 185
Gender, fatty liver and GGT 176
Comparative cytotoxic and cytoprotective effects of taurohyodeoxycholic acid (THDCA) and tauroursodeoxycholic acid (TUDCA) in HepG2 cell line. 176
Nonalcoholic fatty liver disease and aging: epidemiology to management 172
Increased appearance rate of 27-hydroxycholesterol in vivo in hypercholesterolemia: A possible compensatory mechanism. 171
Magnetic resonance for quantitative assessment of liver steatosis: a new potential tool to monitor antiretroviral-drug-related toxicities. 168
Risk factors for hospital readmission of elderly patients 166
Is nonalcoholic steatohepatitis associated with a high-though-normal thyroid stimulating hormone level and lower cholesterol levels? 166
Short-term multidisciplinary non-pharmacological intervention is effective in reducing liver fat content assessed non-invasively in patients with nonalcoholic fatty liver disease (NAFLD) 163
Hepatocellular carcinoma in a patient treated with efalizumab for psoriasis. 162
Review article: the metabolic syndrome and non-alcoholic fatty liver disease 160
Pathogenesis and significance of hepatitis C virus steatosis: An update on survival strategy of a successful pathogen 159
Human Immunodeficiency Virus Is the Major Determinant of Steatosis and Hepatitis C Virus of Insulin Resistance in Virus-associated Fatty Liver Disease. 159
Review article: diabetes, genetics and ethnicity 157
Risk for cardiovascular events in an Italian population of patients with type 2 diabetes 157
Effect of liver cirrhosis on the systemic availability of naltrexone in humans 155
Liver and kidney foreign bodies granulomatosis in a patient with malocclusion, bruxism, and worn dental prostheses 154
Hepatitis C virus-infected patients are 'spared' from the metabolic syndrome but not from insulin resistance. A comparative study of nonalcoholic fatty liver disease and hepatitis C virus-related steatosis 151
In Vivo Degradation of Cholesterol to Bile Acids Is Reduced in Patients Receiving Parenteral Nutrition. 151
Decreased hepatic expression of PPAR-gamma coactivator-1 in cholesterol cholelithiasis. 151
Is liver fat detrimental to vessels?: intersections in the pathogenesis of NAFLD and atherosclerosis 150
Treatment of atherogenic liver based on the pathogenesis of nonalcoholic Fatty liver disease: a novel approach to reduce cardiovascular risk? 148
Incidence of gallstone disease in Italy: Results from a multicenter, population-based Italian study (the MICOL project) 148
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 147
The hepatitis C virus-associated dysmetabolic syndrome. 147
Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology. 147
Classical and innovative insulin sensitizing drugs for the prevention and treatment of NAFLD 146
Endocrine and liver interaction: the role of endocrine pathways in NASH 146
Cholesterol absorption in cirrhosis: the role of total and individual bile acid pool size 143
Natural history of gallstone disease: Expectant management or active treatment? Results from a population-based cohort study. 142
Patogenesi della colelitiasi. I. Colelitiasi colesterinica. 141
From NAFLD in clinical practice to answers from guidelines. 141
Bile acid feeding and hepatic sterol metabolism: effect of deoxycholic acid. 141
Effects of acute changes of bile acid pool composition on biliary lipid secretion 139
Statins and HCV: a complex issue 139
Intestinal solubilization, absorption, pharmacokinetics and bioavailability of chenodeoxycholic acid. 138
Nonalcoholic fatty liver disease in HIV-infected persons: epidemiology and the role of nucleoside reverse transcriptase inhibitors. 138
Effect of taurohyodeoxycholic acid on biliary lipid secretion in humans 137
Chronic hepatitis C virus infection and atherosclerosis: Clinical impact and mechanisms. 137
Do diabetes and obesity promote hepatic fibrosis in familial heterozygous hypobetalipoproteinemia? 137
Chicken or egg turned into head or belly 136
Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: An open question 135
Progetto MICOL - Multicentrica Italiana Colelitiasi 135
Advances in the comprehension of the pathophysiology of bile secretion 134
NAFLD and cardiovascular risk: direct evidence for the tale of two ages. 133
Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee. 133
Effect of the selective expansion of cholic acid pool on bile lipid composition: possible mechanism of bile acid induced biliary cholesterol desaturation. 132
Of liver, whisky and plants: A requiem for colchicine in alcoholic cirrhosis? 132
Determinants of bile secretion: effect of bile salt structure on bile flow and biliary cation secretion 131
The effect of chenodeoxycholic acid (CDCA) on cholesterol absorption. 130
Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD. 129
Review article: hepatic steatosis and insulin resistance 129
Liver and diabetes. A vicious circle 129
Is cholangiocarcinoma another complication of insulin resistance: A report of three cases 128
Nonalcoholic fatty liver disease activity score and Brunt's pathologic criteria for the diagnosis of nonalcoholic steatohepatitis: what do they mean and do they agree? 128
Fisiologia della secrezione biliare. 127
The prediction of coronary heart disease mortality as a function of major risk factors in over 30.000 men in the italian RIFLE Pooling Project. A comparison with the MRFIT primary screenees 127
Cardiovascular and Systemic Risk in Nonalcoholic Fatty Liver Disease -Atherosclerosis As a Major Player in the Natural Course of NAFLD. 127
Insulin resistance in nonalcoholic steatohepatitis: necessary but not sufficient - death of a dogma from analysis of therapeutic studies? 126
Metabolic alterations and chronic hepatitis C: treatment strategies. 125
Nonalcoholic fatty liver disease induced by leuprorelin acetate 124
Relationship of serum fetuin-a levels with coronary atherosclerotic burden and NAFLD in patients undergoing elective coronary angiography. 124
Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease. A case-control study 123
Growth hormone plasma levels in nonalcoholic fatty liver disease 123
Influence of age and sex on serum concentrations of total dimeric activin A 123
Apolipoprotein synthesis in nonalcoholic steatohepatitis 123
Non-organ-specific autoantibodies in nonalcoholic fatty liver disease: Prevalence and correlates 123
Hepatic cholesterol and bile acid metabolism in subjects with gallstones: comparative effects of short erm feeding of chenodeoxycholic and ursodeoxycholic acid 122
Hepatitis C and diabetes: the inevitable coincidence? 121
Effect of diabetic autonomic neuropathy on gallbladder kinetics in insulin dependent diabetic patients 121
Genetic determinants of susceptibility and severity in nonalcoholic fatty liver disease. 121
Nonsynonymous mutations within APOB in human familial hypobetalipoproteinemia: evidence for feedback inhibition of lipogenesis and postendoplasmic reticulum degradation of apolipoprotein B. 121
'True' antimitochondrial antibody-negative primary biliary cirrhosis, low sensitivity of the routine assays, or both? 120
Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease 119
Il pool degli acidi biliari quale regolatore del metabolismo epatico del colesterolo: sintesi degli acidi biliari. 119
Dysmetabolic changes associated with HCV: a distinct syndrome? 119
'Endocrine NAFLD' a hormonocentric perspective of nonalcoholic fatty liver disease pathogenesis 118
Presentation of the RIFLE Project : Risk factors and life expectancy. 118
RISK FOR CARDIOVASCULAR EVENTS IN AN ITALIAN POPULATION OF PATIENTS WITH TYPE 2 DIABETES 118
Effect of ursocholic acid on bile lipid secretion and composition 117
Role of body mass index in the prediction of all cause mortality in over 62,000 men and women. The Italian RIFLE Pooling Project. Risk Factor and Life Expectancy. 117
Diet and gallstones in Italy: the cross-sectional MICOL results. 116
MR techniques in the qualitative analysis of liver steatosis: the potential in the differentiation between steatohepatatis and steatosis 116
ESTIMATION OF CARDIOVASCULAR RISK IN TYPE 2 DIABETES 115
Clinical physiology of NAFLD: A critical overview of pathogenesis and treatment 115
Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease. 114
Short-term effects of simvastatin on bile acid synthesis and biliary lipid secretion in human subjects. 113
Anatomia e fisiologia delle vie biliari 113
Non-alcoholic Fatty Liver Disease: a HR-MAS analysis 112
The potential for statins in the chemoprevention andmanagement of hepatocellular carcinoma. 112
Nuclear receptors as potential molecular targets in cholesterol accumulation conditions: Insights from evidence on hepatic cholesterol degradation and gallstone disease in humans 112
The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic fatty liver disease 111
Totale 14192
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48699
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48699
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201818 0000 00 00 00018
2018/20193317 54231130208 232199 25526 84254763881
2019/20205450 399404194358 569865 941502 474172332240
2020/20213733 363139324320 391294 369545 133452257146
2021/20223583 51502394313 87156 261204 392213607403
2022/20233224 363354205326 401583 81312 4023514616
Totale 22359